John Canan's Net Worth

$5.49 Million

Estimate Recalculated Nov 1, 2024 08:52AM EST

Who is John Canan

John Canan has an estimated net worth of $5.49 Million. This is based on reported shares across multiple companies, which include Merck & Co. Inc., MERCK & CO INC, REV Group, Inc., and Acasti Pharma Inc..

SEC CIK

John Canan's CIK is 0001374366

Past Insider Trading and Trends

2009 was John Canan's most active year for acquiring shares with 23 total transactions. John Canan's most active month to acquire stocks was the month of October. 2009 was John Canan's most active year for disposing of shares, totalling 18 transactions. John Canan's most active month to dispose stocks was the month of October. 2014 saw John Canan paying a total of $646,052.34 for 12,913 shares, this is the most they've acquired in one year. In 2012 John Canan cashed out on 51,576 shares for a total of $2,223,370.57, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Merck & Co. Inc.

Sr.V-P Finc-Global Controller
Updated Feb 26, 2014
Form 4
27.23%
2.91K
$56.18
$163.65K
Feb 26, 2014
16.96K
Grant
Feb 24
Form 4
-48.32%
-10.00K
$51.97
-$74.60K
Feb 11, 2014
14.04K
Sale
Feb 11
Form 4
335.39%
40.98K
$44.98
-$276.54K
May 08, 2013
56.46K
Options
May 06 - May 07
Form 4
52.53%
2.66K
$42.52
$112.98K
Feb 27, 2013
10.95K
Grant
Feb 25
Form 4
-85.78%
-30.50K
$44.29
-$1.35M
Aug 02, 2012
8.20K
Sale
Aug 01
Form 4
-9.01%
-3.52K
$43.27
-$571.21K
Jul 26, 2012
38.70K
Options
Jul 24
Form 4
48.46K
May 04, 2012
80.61K
Grant
May 02
Form 4
-6.73%
-2.10K
$38.27
-$301.38K
Apr 26, 2012
32.15K
Options
Apr 24
Form 4
20.42%
4.27K
$38.38
$163.81K
Mar 01, 2012
28.14K
Grant
Feb 28
Form 4
49.70K
May 06, 2011
72.74K
Grant
May 04
Form 4
-8.24%
-1.80K
$32.19
-$217.28K
Mar 01, 2011
22.72K
Options
Feb 28
Form 4
28.65%
3.76K
$32.34
$121.63K
Feb 24, 2011
19.57K
Grant
Feb 22
Form 4
28.49K
May 11, 2010
43.66K
Grant
May 07
Form 4
-9.80%
-1.36K
$37.27
-$190.60K
Mar 04, 2010
14.95K
Options
Mar 02
Form 4
35.95%
2.69K
$37.72
$101.39K
Jan 26, 2010
12.57K
Grant
Jan 08
Form 4
233.70K
Nov 05, 2009
Acq/Dis
Nov 03
Form 3
Nov 05, 2009
Showing 17 results

MERCK & CO INC

Senior V-P, Controller
Updated Nov 04, 2009
Form 4
-100.00%
-233.70K
Nov 04, 2009
Disposition
Nov 03
Form 4
9.68K
Jul 28, 2009
19.20K
Grant
Jul 24
Form 4
36.58K
Apr 27, 2009
45.82K
Grant
Apr 24
Form 4/A
19.12%
1.15K
$23.05
$26.39K
Apr 27, 2009
7.13K
Grant
Mar 04
Form 4
15.70%
940.00
$23.05
$21.67K
Mar 06, 2009
9.04K
Grant
Mar 04
Form 4
31.35K
Mar 04, 2008
39.04K
Grant
Feb 29
Form 4
28.07%
1.27K
$45.44
$57.85K
Mar 03, 2008
7.69K
Grant
Feb 28
Form 4
-13.44%
-704.00
$46.07
-$109.23K
Feb 27, 2008
6.41K
Options
Feb 25
Form 4
23.75K
Mar 06, 2007
28.94K
Grant
Mar 02
Form 4
-39.72%
-1.59K
$44.79
-$250.33K
Jan 17, 2007
4.13K
Options
Jan 15
Form 3
Sep 11, 2006
1.67K
Showing 11 results

REV Group, Inc.

Investor
Updated Dec 12, 2023
Form 4
13.47%
7.08K
Dec 12, 2023
59.67K
Grant
Dec 08
Form 4
17.84%
7.96K
Dec 12, 2022
52.59K
Grant
Dec 08
Form 4
15.37%
5.95K
Dec 13, 2021
44.63K
Grant
Dec 09
Form 4
37.66%
10.58K
Dec 15, 2020
38.69K
Grant
Dec 11
Form 4
11.25%
2.84K
Jan 17, 2020
28.10K
Grant
Feb 06
Form 4
44.55%
7.80K
Dec 20, 2019
25.30K
Grant
Dec 18
Form 4
173.34%
11.10K
Jan 11, 2019
17.50K
Grant
Jan 09
Form 4
380.95%
5.04K
$16.04
$80.85K
Jun 27, 2018
6.36K
Purchase
Jun 25
Form 4
1.36K
Jan 30, 2017
1.36K
Grant
Jan 26
Form 3
Jan 26, 2017
Showing 10 results

Acasti Pharma Inc.

Investor
Updated Sep 30, 2022
Form 4
45.00K
Sep 30, 2022
45.00K
Grant
Sep 28
Form 4
42.10K
Nov 16, 2021
42.10K
Grant
Nov 12
Form 3
Apr 01, 2020
100.00K
Form 3
Feb 22, 2017
40.00K
Showing 4 results